4//SEC Filing
Neurotrope, Inc. 4
Accession 0001144204-15-066386
CIK 0001513856operating
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 3:30 PM ET
Size
17.6 KB
Accession
0001144204-15-066386
Insider Transaction Report
Form 4
Neurotrope, Inc.NTRP
HAFT JAY M
Director
Transactions
- Purchase
Series E Warrant
2015-11-13+41,667→ 41,667 totalExercise: $1.50→ Common Stock (41,667 underlying) - Purchase
Series B Preferred Stock
2015-11-13+416.67→ 41,667 totalExercise: $0.00→ Common Stock (41,667 underlying) - Purchase
Series B Warrant
2015-11-13+41,667→ 41,667 totalExercise: $0.80Exp: 2016-11-13→ Common Stock (41,667 underlying) - Purchase
Series D Warrant
2015-11-13+41,667→ 41,667 totalExercise: $1.00→ Common Stock (41,667 underlying) - Purchase
Series A Warrant
2015-11-13+41,667→ 41,667 totalExercise: $0.80Exp: 2020-11-13→ Common Stock (41,667 underlying) - Purchase
Series C Warrant
2015-11-13+41,667→ 41,667 totalExercise: $1.25Exp: 2020-11-13→ Common Stock (41,667 underlying)
Footnotes (7)
- [F1]The reported securities are included within units with a purchase price of $0.60 per unit, each unit consisting of one one-hundredth of a share of Series B Preferred Stock, one Series A Warrant, one Series B Warrant, one Series C Warrant, one Series D Warrant and one Series E Warrant.
- [F2]The Series B Preferred Stock may be converted at any time by the holder at an initial conversion ratio of one share of Common Stock per one one-hundredth share of Series B Preferred Stock and have no expiration date.
- [F3]Each Series A Warrant allows the reporting person to acquire, at an exercise price of $0.80 per share with an expiration date five years from the date of issuance, one share of Common Stock subject to adjustment.
- [F4]Each Series B Warrant allows the reporting person to acquire, at an exercise price of $0.80 per share with an expiration date of one year from the date of issuance, one share of Common Stock subject to adjustment.
- [F5]Each Series C Warrant allows the reporting person to acquire, at an exercise price of $1.25 per share with an expiration date of five years from the date of issuance, one share of Common Stock subject to adjustment.
- [F6]Each Series D Warrant will be exercisable only if and to the extent that the Series B Warrants are exercised and will expire on the five year anniversary of the date that the Series B Warrant is initially exercised.
- [F7]Each Series E Warrant will be exercisable only if and to the extent that the Series C Warrants are exercised and will expire on the five year anniversary of the date that the Series C Warrant is initially exercised.
Documents
Issuer
Neurotrope, Inc.
CIK 0001513856
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001513856
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 3:30 PM ET
- Size
- 17.6 KB